| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000019406 |
| Receipt No. | R000022446 |
| Scientific Title | Confirmatory clinical trials Radial optic neurotomy for central retinal vein occlusion |
| Date of disclosure of the study information | 2015/11/01 |
| Last modified on | 2021/10/22 (Ver. 4) |
| Basic information | ||
| Public title | Confirmatory clinical trials Radial optic neurotomy for central retinal vein occlusion | |
| Acronym | Confirmatory clinical trials Ron for CRVO | |
| Scientific Title | Confirmatory clinical trials Radial optic neurotomy for central retinal vein occlusion | |
| Scientific Title:Acronym | Confirmatory clinical trials Ron for CRVO | |
| Region |
|
|
| Condition | ||
| Condition | central retinal vein occlusion | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | For macular edema secondary from central retinal vein occlusion cases with insufficient effect of anti-VEGF drugs, we underwent Radial optic neurotomy.
Compare visual acuity, central retinal thickness, and blood flow before and after surgery. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The change of visual acuity at one year after operation |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | For macular edema cases of insufficient effect of central retinal vein occlusion of anti-VEGF drugs, and underwent Radial optic neurotomy.
|
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | In patients with macular edema due to insufficient effect of central retinal vein occlusion of the anti-VEGF drugs in hospital in Nagasaki University Hospital Ophthalmology.
1)Patients with macular edema due to central retinal vein occlusion 2)central macular thicknes=>250,micro,m 3) Point visual acuity less than 0.7 4) It does not respond to treatment with anti-VEGF drugs against macular edema associated with central retinal vein occlusion, patient blood flow does not increase. 5)At the time of obtaining informed consent, age of more than 20-year-old patient 6)Patient after receiving a sufficient explanation Upon participation in this study,on the thorough understanding,that document consent is obtained by the free will of the patient himself |
|||
| Key exclusion criteria | 1)Patients leading to neovascular glaucoma.
2)Patients already collateral circulation are made. 3)Patients principal investigator has determined to be inappropriate as a subject. |
|||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Nagasaki University Hospital | ||||||
| Division name | Department of Ophthalmology | ||||||
| Zip code | |||||||
| Address | 1-7-1 Sakamoto,Nagasaki | ||||||
| TEL | 095-819-7345 | ||||||
| tkitaoka@nagasaki-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Nagasaki University Hospital | ||||||
| Division name | Department of Ophthalmology | ||||||
| Zip code | |||||||
| Address | 1-7-1 Sakamoto,Nagasaki | ||||||
| TEL | 095-819-7345 | ||||||
| Homepage URL | |||||||
| makimaki@nagasaki-u.ac.jp | |||||||
| Sponsor | |
| Institute | Nagasaki University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022446 |